Patents by Inventor Gregory H. Altman

Gregory H. Altman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8894992
    Abstract: The invention relates to compositions comprising adipose tissue, a silk fibroin material and a compound of the structure The composition is administered to a site of a soft tissue condition including those of breast tissue. The silk fibroin material can be in the form of a silk hydrogel, a silk film, a silk scaffold, a silk sheet, a silk porous material, a silk fiber or a combination of those materials. The silk material may be substantially sericin free.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: November 25, 2014
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Adam L. Collette, Rebecca L. Horan, Jingsong Chen, Gregory H. Altman, Wha Bin Im
  • Publication number: 20140277000
    Abstract: A method of using a biocompatible surgical silk mesh prosthetic device in body aesthetics and body contouring, the surgical mesh employing a knit pattern that substantially prevents unraveling and preserves the stability of the mesh device, especially when the mesh device is cut. An example prosthetic device employs a knitted mesh including at least two yarns laid in a knit direction and engaging each other to define a plurality of nodes. The at least two yarns include a first yarn and a second yarn extending between and forming loops about two nodes. The second yarn has a higher tension at the two nodes than the first yarn. the second yarn substantially prevents the first yarn from moving at the two nodes and substantially prevents the knitted mesh from unraveling at the nodes.
    Type: Application
    Filed: May 29, 2014
    Publication date: September 18, 2014
    Applicant: Allergan, Inc.
    Inventors: Enrico Mortarino, Gregory H. Altman, John Gross
  • Publication number: 20140206839
    Abstract: The present specification provides for methods for purifying fibroins, purified fibroins, methods of conjugating biological and synthetic molecules to fibroins, fibroins conjugated to such molecules, methods of making fibroin hydrogels, fibroin hydrogels and fibroin hydrogel formulations useful for a variety of medical uses, including, without limitation uses as bulking agents, tissue space fillers, templates for tissue reconstruction or regeneration, cell culture scaffolds for tissue engineering and for disease models, surface coating to improve medical device function, or drug delivery devices.
    Type: Application
    Filed: March 31, 2014
    Publication date: July 24, 2014
    Applicant: Allergan, Inc.
    Inventors: Gregory H. Altman, Rebecca L. Horan, Adam L. Collette, Jingsong Chen, Dennis Van Epps
  • Publication number: 20140194987
    Abstract: The present specification provides for methods for purifying fibroins, purified fibroins, methods of conjugating biological and synthetic molecules to fibroins, fibroins conjugated to such molecules, methods of making fibroin hydrogels, fibroin hydrogels and fibroin hydrogel formulations useful for a variety of medical uses, including, without limitation uses as bulking agents, tissue space fillers, templates for tissue reconstruction or regeneration, cell culture scaffolds for tissue engineering and for disease models, surface coating to improve medical device function, or drug delivery devices.
    Type: Application
    Filed: January 31, 2014
    Publication date: July 10, 2014
    Applicant: Allergan, Inc.
    Inventors: Gregory H. Altman, Rebecca L. Horan, Adam L. Collette, Jingsong Chen, Dennis Van Epps
  • Patent number: 8741281
    Abstract: The specification discloses compositions and methods for treating a soft tissue defect of an individual.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: June 3, 2014
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Adam L. Collette, Rebecca L. Horan, Jingsong Chen, Gregory H. Altman, Wha Bin Im
  • Publication number: 20140105951
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicant: Allergan, Inc.
    Inventors: Gregory H. Altman, Rebecca Horan, David J. Horan, Jingsong Chen
  • Patent number: 8685426
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: April 1, 2014
    Assignee: Allergan, Inc.
    Inventors: Gregory H. Altman, Jingson Chen, Rebecca L. Horan, David J. Horan
  • Publication number: 20140088700
    Abstract: A method of using a silk derived medical device in a two stage breast reconstruction procedure.
    Type: Application
    Filed: September 16, 2013
    Publication date: March 27, 2014
    Applicant: Allergan, Inc.
    Inventors: Enrico Mortarino, Gregory H. Altman, Jeff Ippolito
  • Patent number: 8633027
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: January 21, 2014
    Assignee: Allergan, Inc.
    Inventors: Gregory H. Altman, Jingson Chen, Rebecca L. Horan, David J. Horan
  • Patent number: 8628791
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: January 14, 2014
    Assignee: Allergan, Inc.
    Inventors: Gregory H. Altman, Jingson Chen, Rebecca L. Horan, David J. Horan
  • Patent number: 8623398
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: January 7, 2014
    Assignee: Allergan, Inc.
    Inventors: Gregory H. Altman, Rebecca Horan, David J. Horan, Jingsong Chen
  • Publication number: 20130253646
    Abstract: Methods for determining suitability of an implantable silk scaffold for use in human soft tissue repair by implanting a silk scaffold in a quadruped. The silk scaffold is completely or essentially completely bioresorbed by twelve months after implantation, the silk scaffold (to the extent remaining) with ingrown tissue shows at least about a 60% strength increase by 12 months after implantation, and the thickness of the silk scaffold (to the extent remaining) with ingrown tissue increases by more than 100% by 12 months after implantation.
    Type: Application
    Filed: May 20, 2013
    Publication date: September 26, 2013
    Applicant: Allergan, Inc.
    Inventors: Gregory H. Altman, Enrico Mortarino, Raymond E. Olsen
  • Publication number: 20130245757
    Abstract: Methods for determining suitability of an implantable silk scaffold for use in human soft tissue repair by implanting a silk scaffold in a quadruped. The silk scaffold is completely or essentially completely bioresorbed by twelve months after implantation, the silk scaffold (to the extent remaining) with ingrown tissue shows at least about a 60% strength increase by 12 months after implantation, and the thickness of the silk scaffold (to the extent remaining) with ingrown tissue increases by more than 100% by 12 months after implantation.
    Type: Application
    Filed: August 31, 2012
    Publication date: September 19, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Gregory H. Altman, Enrico Mortarino, Raymond E. Olsen
  • Publication number: 20130116785
    Abstract: Methods for determining suitability of an implantable silk scaffold for use in human soft tissue repair by implanting a silk scaffold in a quadruped. The silk scaffold is completely or essentially completely bioresorbed by twelve months after implantation, the silk scaffold (to the extent remaining) with ingrown tissue shows at least about a 60% strength increase by 12 months after implantation, and the thickness of the silk scaffold (to the extent remaining) with ingrown tissue increases by more than 100% by 12 months after implantation.
    Type: Application
    Filed: February 13, 2012
    Publication date: May 9, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Gregory H. Altman, Enrico Mortarino, Raymond E. Olsen
  • Publication number: 20130116711
    Abstract: Methods for determining suitability of an implantable silk scaffold for use in human soft tissue repair by implanting a silk scaffold in a quadruped. The silk scaffold can maintain at least 90% of its time zero strength at one month in vivo after implantation. The silk scaffold can maintain at least 90% of its time zero strength over a multi-month period in vivo after implantation.
    Type: Application
    Filed: November 4, 2011
    Publication date: May 9, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Gregory H. Altman, Enrico Mortarino, Raymond E. Olsen
  • Patent number: 8420077
    Abstract: The present specification provides for methods for purifying fibroins, purified fibroins, methods of conjugating biological and synthetic molecules to fibroins, fibroins conjugated to such molecules, methods of making fibroin hydrogels, fibroin hydrogels and fibroin hydrogel formulations useful for a variety of medical uses, including, without limitation uses as bulking agents, tissue space fillers, templates for tissue reconstruction or regeneration, cell culture scaffolds for tissue engineering and for disease models, surface coating to improve medical device function, or drug delivery devices.
    Type: Grant
    Filed: April 20, 2010
    Date of Patent: April 16, 2013
    Assignee: Allergan, Inc.
    Inventors: Gregory H. Altman, Rebecca L. Horan, Adam L. Collette, Jingsong Chen
  • Publication number: 20120296352
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Application
    Filed: July 30, 2012
    Publication date: November 22, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Gregory H. Altman, Jingsong Chen, Rebecca Horan, David J. Horan
  • Publication number: 20120296351
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Application
    Filed: July 30, 2012
    Publication date: November 22, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Gregory H. Altman, Jingsong Chen, Rebecca Horan, David J. Horan
  • Publication number: 20120296443
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Application
    Filed: July 30, 2012
    Publication date: November 22, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Gregory H. Altman, Jingsong Chen, Rebecca Horan, David J. Horan
  • Publication number: 20120294906
    Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.
    Type: Application
    Filed: July 30, 2012
    Publication date: November 22, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Gregory H. Altman, Jingsong Chen, Rebecca Horan, David J. Horan